ACC inhibitor alone or co-administered with a DGAT2 inhibitor in patients with non-alcoholic fatty liver disease: two parallel, placebo-controlled, randomized phase 2a trials
ACC 抑制剂单独使用或与 DGAT2 抑制剂联合使用治疗非酒精性脂肪肝患者：两项平行、安慰剂对照、随机 2a 期试验
期刊:Nature Medicine
影响因子:58.7
doi:10.1038/s41591-021-01489-1
Roberto A Calle #, Neeta B Amin #, Santos Carvajal-Gonzalez, Trenton T Ross, Arthur Bergman, Sudeepta Aggarwal, Collin Crowley, Anthony Rinaldi, Jessica Mancuso, Naresh Aggarwal, Veena Somayaji, Malgorzata Inglot, Theresa A Tuthill, Kou Kou, Magalie Boucher, Greg Tesz, Robert Dullea, Kendra K Bence,
